CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 33 enrolled
Drug / intervention
Ketaminedrug
Likely dose
Ketamine 2 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02512055
NCT02512055Phase 4Completed
CompareCT.gov

Ketamine Tolerance in Children After Repeated Administrations During Radiotherapy Sessions

Baskent University·interventional·Posted Jul 30, 2015·Updated Jul 30, 2015

In Brief

A Phase 4 clinical trial evaluating Ketamine for Conscious Sedation Failure During Procedure. Completed, enrolled 33 participants.

Detailed Summary

Ketamine provides a safety zone for sedated but spontaneously ventilated children especially in remote conditions such as radiotherapy units where sedation is an essential practice for children to keep calm and motionless In this study, investigators planned to analyse ketamine doses needed and the recovery times in pediatric oncology patients undergoing repeated radiotherapy sessions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsConscious Sedation Failure During Procedure
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJul 30, 2015
Enrollment StartMay 1, 2012
Primary CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 10.9 years ago

Interventions

Ketaminedrug

Repeated ketamine 2 mg/kg administration intravenously for sedation during each radiotherapy sessions